AstraZeneca (AZNCF) Institutional Ownership $155.67 +5.19 (+3.45%) As of 02:25 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartDividendFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for AstraZeneca (OTCMKTS:AZNCF)CurrentInstitutional OwnershipPercentage40.87%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$154.61KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$15.04M Get AZNCF Insider Trade Alerts Want to know when executives and insiders are buying or selling AstraZeneca stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AZNCF Institutional Buying and Selling by Quarter AstraZeneca Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/22/2025 Boston Common Asset Management LLC182,435$25.30M0.7%-1.9%0.000% 4/3/2025 Boston Common Asset Management LLC185,930$27.01M0.8%-14.2%0.000% 1/15/2025 Boston Common Asset Management LLC216,775$28.26M0.8%-17.3%0.000% 10/22/2024 Eagle Bay Advisors LLC1,001$156K0.1%N/A0.000% 10/9/2024 Boston Common Asset Management LLC262,273$40.77M1.1%-9.2%0.000% 7/8/2024 Boston Common Asset Management LLC288,790$45.11M1.2%-3.6%0.000% 5/16/2024Kennedy Capital Management LLC37,554$5.07M0.1%N/A0.000% 1/9/2024 Boston Common Asset Management LLC301,010$40.58M0.9%-2.8%0.000% 10/11/2023 Boston Common Asset Management LLC309,762$41.97M1.0%-1.1%0.000% 7/24/2023 Boston Common Asset Management LLC313,065$44.88M1.0%+15.5%0.000% 5/17/2023 Boston Common Asset Management LLC271,130$37.65M0.8%N/A0.000% 5/1/2023Vigilant Capital Management LLC647$90K0.0%-16.2%0.000% (Data available from 1/1/2016 forward) AZNCF Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AZNCF shares? During the previous two years, the following institutional investors and hedge funds held shares of AstraZeneca shares: Boston Common Asset Management LLC ($25.30M), and Kennedy Capital Management LLC ($5.07M), Eagle Bay Advisors LLC ($156K).Learn more on AstraZeneca's institutional investors. What percentage of AstraZeneca's stock is owned by institutional investors? 40.87% of AstraZeneca's stock is owned by institutional investors. Learn more on AZNCF's institutional investor holdings. Which institutional investors have been buying AstraZeneca's stock? The following institutional investors have purchased AstraZeneca's stock in the last 24 months: Kennedy Capital Management LLC ($37.55K), and Eagle Bay Advisors LLC ($1.00K). How much institutional buying is happening at AstraZeneca? Institutional investors have bought a total of 1,001 shares in the last 24 months. This purchase volume represents approximately $154.61K in transactions. Which of AstraZeneca's major shareholders have been selling company stock? The following institutional investors have sold AstraZeneca stock in the last 24 months: Boston Common Asset Management LLC ($106.36K). How much institutional selling is happening at AstraZeneca? Institutional investors have sold a total of 106,355 shares in the last 24 months. This volume of shares sold represents approximately $15.04M in transactions. This page (OTCMKTS:AZNCF) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Fed Just Froze You Out (Again)The Fed’s holding rates steady—again. No clarity. No yield. No relief. But one income strategy is quietly t...Investors Alley | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredSomething BIG is about to hit the stock marketMost investors won’t see it coming—but Weiss Ratings says a major market event is brewing. Their system jus...Weiss Ratings | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZNCF Stock Alerts